Profund Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,892
| Closed | -$126K | – | 1161 |
|
|
2024
Q2 | $126K | Sell |
30,892
-15,510
| -33% | -$63.4K | ﹤0.01% | 1033 |
|
|
2024
Q1 | $731K | Sell |
46,402
-11,837
| -20% | -$187K | 0.03% | 446 |
|
|
2023
Q4 | $882K | Buy |
58,239
+24,063
| +70% | +$365K | 0.04% | 353 |
|
|
2023
Q3 | $686K | Sell |
34,176
-11,355
| -25% | -$228K | 0.04% | 378 |
|
|
2023
Q2 | $1.28M | Buy |
45,531
+6,643
| +17% | +$187K | 0.07% | 257 |
|
|
2023
Q1 | $669K | Buy |
+38,888
| New | +$669K | 0.04% | 416 |
|